查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1612589

Biperiden市場：按劑量、按應用 - 全球預測 2025-2030

Biperiden Market by Administration (Injection, Oral), Application (Drug-induced Movement Disorders, Parkinson Disease, Touret Syndrome) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年Biperiden市值為3.6427億美元，預計到2024年將達到3.847億美元，複合年成長率為5.69%，預計到2030年將達到5.3676億美元。

Biperiden是一種抗膽鹼能藥物，主要用於治療帕金森氏症和相關的運動障礙。Biperiden的市場範圍包括其在解決帕金森氏症和其他神經退化性疾病（例如震顫、強直和心搏過緩）的運動症狀方面的需求和用途。其最終用途包括醫院、診所和家庭護理機構，在這些場所，老年人特別容易患帕金森氏症，而且這種疾病的發生率正在上升。目前的市場成長受到神經系統疾病發病率增加、意識提高以及更好治療選擇的可用性的影響。然而，也有機會探索藥物對次要適應症的功效，特別是在心理健康方面，例如抗精神病藥物引起的錐體外系症狀的治療。利用這些機會的建議包括研究和開發改進製劑，使患者更容易獲得治療，例如緩釋性釋放、提高生物利用度和減少副作用，這包括加強努力。

主要市場統計
基準年[2023] 3.6427 億美元
預計年份 [2024] 3.847 億美元
預測年份 [2030] 53676萬美元
複合年成長率（%） 5.69%

然而，阻礙市場成長的挑戰包括潛在副作用（口乾、便秘、視力模糊、混亂）等限制，這可能會妨礙長期使用。來自替代療法（包括更新、更有效的帕金森氏症療法）的競爭也構成了威脅。監管障礙以及持續更新安全性和有效性的需要也增加了挑戰。這個市場為聯合治療的創新提供了肥沃的土壤，並有可能改善患者的治療效果。另一個有前景的研究領域是個人化醫療，其使用是根據個人的遺傳特徵量身定做的，以最大限度地提高療效並最大限度地減少副作用。Biperiden市場的本質特徵是由未滿足的臨床需求驅動的穩定成長，但受到重大障礙的抑制。與以神經病學為重點的學術機構和生物技術公司的創新和策略聯盟對於在動態的製藥領域保持競爭力和持續成長至關重要。

市場動態：揭示快速發展的Biperiden市場的關鍵市場洞察

供需的動態交互作用正在改變比Biperiden市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助消費行為及其對製造業的影響。

  • 市場促進因素
    • 擴大比Biperiden在帕金森氏症治療的全球使用
    • 在治療藥物引起的運動障礙的藥物開發中增加Biperiden的使用
  • 市場限制因素
    • 比Biperiden生產認知度低、成本高
  • 市場機會
    • 提高Biperiden登藥物適用性的研發進展
    • 製藥公司加大對比Biperiden生產的投資
  • 市場問題
    • Biperiden可能對健康的影響

波特的五力：駕馭Biperiden市場的策略工具

波特的五力框架是了解Biperiden市場競爭格局的關鍵工具。波特的五力框架描述了評估公司競爭和探索策略機會的清晰方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解Biperiden市場的外部影響

外部宏觀環境因素在塑造Biperiden市場的表現動態發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助企業預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析：了解Biperiden市場的競爭格局

Biperiden市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、細分和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣：Biperiden市場供應商的績效評估

FPNV定位矩陣是評估Biperiden市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議：繪製比Biperiden市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，Biperiden市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

該報告對涵蓋關鍵焦點細分市場的市場進行了全面分析。

1.市場滲透率：對當前市場環境的詳細審查，主要企業的廣泛資料，評估他們在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有細分市場的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、主要產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策。

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品和地區提供最佳投資機會？

3.塑造市場的關鍵技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球Biperiden治療巴金森氏症的使用量增加
      • 在治療藥物引起的運動障礙的藥物開發中增加使用Biperiden
    • 抑制因素
      • 比Biperiden生產認知度低、成本高
    • 機會
      • 持續研發，增強Biperiden藥物的適用性
      • 製藥公司對比Biperiden生產的新投資
    • 任務
      • 比Biperiden相關的潛在健康影響
  • 市場區隔分析
    • 給藥方式：由於易於使用和患者依從性，口服給藥越來越受歡迎
    • 用途：Biperiden作為有效抗膽鹼能藥物在藥物引起的運動障礙的推廣
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 法律
    • 環境

第6章Biperiden市場：依劑量

  • 介紹
  • 注射
  • 口服

第7章Biperiden市場：依應用

  • 介紹
  • 藥物引起的運動障礙
  • 帕金森氏症
  • 妥瑞症

第8章 美洲比Biperiden市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太比哌Biperiden市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章 歐洲、中東和非洲Biperiden市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 默克簽署 6.1 億美元 Biovacs 收購臨床前神經退化生物技術公司 Caraway 的協議
    • 艾伯維 (AbbVie) 透過生物技術收購獲得帕金森氏症治療藥物
    • Serina 和 AgeX 共同開發進行性帕金森氏症的治療方法
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • AbbVie Inc.
  • ACTYLIS
  • Adooq Bioscience LLC
  • BioCrick BioTech
  • BIoTechne Corporation
  • Clearsynth
  • Enomark
  • MANUS AKTTEVA BIOPHARMA LLP
  • Merck KGaA
  • NIKSAN PHARMACEUTICAL
  • Rafa Laboratories Ltd.
  • SAKHIYA PHARMA CHEM
  • Salvavidas Pharmaceutical Pvt. Ltd.
  • Shreeji Pharma International
  • Simson Pharma
  • Synnat Pharma
Product Code: MRR-351BAD503D4E

The Biperiden Market was valued at USD 364.27 million in 2023, expected to reach USD 384.70 million in 2024, and is projected to grow at a CAGR of 5.69%, to USD 536.76 million by 2030.

Biperiden is an anticholinergic drug primarily used to treat Parkinson's disease and related movement disorders. The market scope for Biperiden encompasses its necessity and application in addressing the motor symptoms of Parkinson's and other neurodegenerative conditions, including tremors, rigidity, and bradykinesia. Its end-use spans hospitals, clinics, and home care settings, particularly given the rising geriatric population vulnerable to Parkinson's. Current market growth is influenced by increasing incidences of neurological disorders, greater awareness, and the availability of better treatment options. However, opportunities also lie in exploring the drug's efficacy for secondary indications, especially within mental health, such as managing extrapyramidal symptoms induced by antipsychotics. A recommendation to capitalize on these opportunities includes intensifying R&D efforts to improve Biperiden formulations that offer extended release, enhance bioavailability, and lower side-effect profiles, thus making the treatment more patient-friendly.

KEY MARKET STATISTICS
Base Year [2023] USD 364.27 million
Estimated Year [2024] USD 384.70 million
Forecast Year [2030] USD 536.76 million
CAGR (%) 5.69%

Yet, challenging the market growth are limitations such as potential adverse effects (dry mouth, constipation, blurred vision, confusion), which may deter long-term use. Competition from alternative therapies, including newer, more effective Parkinson's drugs, also poses a threat. Regulatory hurdles and the necessity for continuous updates on safety and efficacy add to the challenges. Nonetheless, the market offers fertile ground for innovation in the form of combination therapies that may enhance patient outcomes. Another promising research area lies in personalized medicine, tailoring Biperiden use to individual genetic profiles to maximize efficacy and minimize side effects. The nature of the Biperiden market is one characterized by steady growth, driven by unmet clinical needs but tempered by significant barriers. Innovation and strategic collaborations with academic institutions and biotech firms focused on neurology will be essential to maintain competitiveness and to sustain growth in the dynamic pharmaceutical landscape.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Biperiden Market

The Biperiden Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing use of biperiden to treat parkinson's disease globally
    • Rising usage of biperiden in drug developement of drug-induced movement disorders
  • Market Restraints
    • Limited awareness and high cost of biperiden manufacturing
  • Market Opportunities
    • Ongoing research and development to enhance the applicability of biperiden-based drugs
    • Emerging investments by pharmaceutical companies in biperiden production
  • Market Challenges
    • Potential health affects associated with biperiden

Porter's Five Forces: A Strategic Tool for Navigating the Biperiden Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Biperiden Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Biperiden Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Biperiden Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Biperiden Market

A detailed market share analysis in the Biperiden Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Biperiden Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Biperiden Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Biperiden Market

A strategic analysis of the Biperiden Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Biperiden Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AbbVie Inc., ACTYLIS, Adooq Bioscience LLC, BioCrick BioTech, Biotechne Corporation, Clearsynth, Enomark, MANUS AKTTEVA BIOPHARMA LLP, Merck KGaA, NIKSAN PHARMACEUTICAL, Rafa Laboratories Ltd., SAKHIYA PHARMA CHEM, Salvavidas Pharmaceutical Pvt. Ltd., Shreeji Pharma International, Simson Pharma, and Synnat Pharma.

Market Segmentation & Coverage

This research report categorizes the Biperiden Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Administration, market is studied across Injection and Oral.
  • Based on Application, market is studied across Drug-induced Movement Disorders, Parkinson Disease, and Touret Syndrome.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing use of biperiden to treat parkinson's disease globally
      • 5.1.1.2. Rising usage of biperiden in drug developement of drug-induced movement disorders
    • 5.1.2. Restraints
      • 5.1.2.1. Limited awareness and high cost of biperiden manufacturing
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing research and development to enhance the applicability of biperiden-based drugs
      • 5.1.3.2. Emerging investments by pharmaceutical companies in biperiden production
    • 5.1.4. Challenges
      • 5.1.4.1. Potential health affects associated with biperiden
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Administration: Increasing preferences for Oral administration owing to their ease of use and patient compliance
    • 5.2.2. Application: Proliferation of biperiden in drug-induced movement disorders as potent anticholinergic agent
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Biperiden Market, by Administration

  • 6.1. Introduction
  • 6.2. Injection
  • 6.3. Oral

7. Biperiden Market, by Application

  • 7.1. Introduction
  • 7.2. Drug-induced Movement Disorders
  • 7.3. Parkinson Disease
  • 7.4. Touret Syndrome

8. Americas Biperiden Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Biperiden Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Biperiden Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
    • 11.3.1. Merck Seals USD 610 Million Biobucks Deal to Acquire Preclinical Neurodegenerative Biotech Caraway
    • 11.3.2. AbbVie Acquires Parkinson's Drug in Latest Biotech Buyout
    • 11.3.3. Serina-AgeX Merger to Develop Treatment for Advanced Parkinson's
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. AbbVie Inc.
  • 3. ACTYLIS
  • 4. Adooq Bioscience LLC
  • 5. BioCrick BioTech
  • 6. Biotechne Corporation
  • 7. Clearsynth
  • 8. Enomark
  • 9. MANUS AKTTEVA BIOPHARMA LLP
  • 10. Merck KGaA
  • 11. NIKSAN PHARMACEUTICAL
  • 12. Rafa Laboratories Ltd.
  • 13. SAKHIYA PHARMA CHEM
  • 14. Salvavidas Pharmaceutical Pvt. Ltd.
  • 15. Shreeji Pharma International
  • 16. Simson Pharma
  • 17. Synnat Pharma

LIST OF FIGURES

  • FIGURE 1. BIPERIDEN MARKET RESEARCH PROCESS
  • FIGURE 2. BIPERIDEN MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BIPERIDEN MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BIPERIDEN MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BIPERIDEN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BIPERIDEN MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BIPERIDEN MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS BIPERIDEN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS BIPERIDEN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES BIPERIDEN MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES BIPERIDEN MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC BIPERIDEN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC BIPERIDEN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA BIPERIDEN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BIPERIDEN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. BIPERIDEN MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. BIPERIDEN MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BIPERIDEN MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BIPERIDEN MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BIPERIDEN MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIPERIDEN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BIPERIDEN MARKET DYNAMICS
  • TABLE 7. GLOBAL BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BIPERIDEN MARKET SIZE, BY INJECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIPERIDEN MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIPERIDEN MARKET SIZE, BY DRUG-INDUCED MOVEMENT DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BIPERIDEN MARKET SIZE, BY PARKINSON DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIPERIDEN MARKET SIZE, BY TOURET SYNDROME, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS BIPERIDEN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES BIPERIDEN MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC BIPERIDEN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA BIPERIDEN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. BIPERIDEN MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 101. BIPERIDEN MARKET, FPNV POSITIONING MATRIX, 2023